0001209191-19-053134.txt : 20191015
0001209191-19-053134.hdr.sgml : 20191015
20191015160330
ACCESSION NUMBER: 0001209191-19-053134
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191014
FILED AS OF DATE: 20191015
DATE AS OF CHANGE: 20191015
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wilson Jason Douglas
CENTRAL INDEX KEY: 0001662395
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37785
FILM NUMBER: 191150994
MAIL ADDRESS:
STREET 1: C/O REATA PHARMACEUTICALS, INC.
STREET 2: 2801 GATEWAY DR. SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001358762
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113651945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2801 GATEWAY DRIVE SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
BUSINESS PHONE: 972-865-2206
MAIL ADDRESS:
STREET 1: 2801 GATEWAY DRIVE SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-10-14
0
0001358762
REATA PHARMACEUTICALS INC
RETA
0001662395
Wilson Jason Douglas
2801 GATEWAY DRIVE
SUITE 150
IRVING
TX
75063
0
1
0
0
Executive VP of Operations
Class A common stock
2019-10-14
4
C
0
15000
A
22350
D
Class A common stock
2019-10-14
4
S
0
15000
100.00
D
7350
D
Class A common stock
2019-10-15
4
C
0
15000
A
22350
D
Class A common stock
2019-10-15
4
S
0
11800
145.5452
D
10550
D
Class A common stock
2019-10-15
4
S
0
300
146.6117
D
10250
D
Class A common stock
2019-10-15
4
S
0
2900
148.4619
D
7350
D
Class B common stock
2019-10-14
4
C
0
15000
D
Class A common stock
15000
33827
D
Class B common stock
2019-10-15
4
C
0
15000
D
Class A common stock
15000
18827
D
The conversions and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 26, 2018.
The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $145.26 to $145.855. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $146.48 to $146.775. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $148.22 to $149.04. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ Michael D. Wortley, attorney-in-fact
2019-10-15